Recurrence: all 3,523 studies
Page 22 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and GlioblastomaTerminatedNCT04047303Phase 1
- Camrelizumab Combined With Apatinib for Recurrent Resistant GTNCompletedNCT04047017Phase 2
- Relapse in Anorexia Nervosa. A Cohort StudyCompletedNCT04046926
- A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple MyelomaTerminatedNCT04036461Phase 1
- A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in KoreaCompletedNCT04036448
- CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)TerminatedNCT04034446Early Phase 1
- γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)Status unknownNCT04028440Early Phase 1
- Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP RegimenStatus unknownNCT04026269Phase 1/2
- Mechanisms of COPD Exacerbation RecurrenceStatus unknownNCT04024735
- Simvastatin in the Prevention of Recurrent PancreatitisTerminatedNCT04021498Phase 3
- Pituitary Adenoma and Serum LipidStatus unknownNCT04021212
- Improved Prediction of Recurrent Stroke and Detection of Small Volume StrokeTerminatedNCT04019483
- CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDSCompletedNCT04017546Phase 1
- Tri Association in Patient With Advanced Epithelial Ovarian Cancer in RelapseStatus unknownNCT04015739Phase 2
- A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell MalignanciesStatus unknownNCT04011293Early Phase 1
- Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte MalignanciesStatus unknownNCT04008394Phase 1
- Ex-vivo Expanded γδ T Lymphocytes in Patients With Refractory/Relapsed Acute Myeloid LeukaemiaStatus unknownNCT04008381Phase 1
- Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple MyelomaStatus unknownNCT04003168Phase 1
- Study of TQB2450 Injection in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell LymphomaTerminatedNCT04002622Phase 2
- Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung CancerCompletedNCT03999710Phase 2
- A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory MalignanciesWithdrawnNCT03999658Phase 2
- Intraperitoneal Polypropylene Light Weight Wide Pore Soft Mesh Repair for Complex Ventral Hernia.CompletedNCT03994588Not applicable
- A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)Active, not recruitingNCT03989414Phase 1/2
- A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian CancerCompletedNCT03989336Phase 2
- Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT03985189Phase 1
- CDIAG Regimen in the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT03985007Phase 2
- A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial CancerActive, not recruitingNCT03981796Phase 3
- Clinical Efficacy of Conventional and Diode Laser-Assisted Frenectomy in Patients With Abnormal Different Frenum Insertions: A Retrospective StudyCompletedNCT03965455
- Clostridium Difficile Infection (CDI) in Hematologic Patients.Status unknownNCT03964844
- Endoscopic Submucosal Dissection vs Local Laparoscopic Surgical Resection (TAMIS/TEO) in Early Rectal NeoplasiasCompletedNCT03959839Not applicable
- Evaluation of a Motion-Activated Refusal-Skills Training Video Game for Prevention of Substance Use Disorder RelapseCompletedNCT03957798Not applicable
- Efficacy of Kangliuwan for Recurrent Grade IV GliomaStatus unknownNCT03949192
- Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCRStatus unknownNCT03947736
- Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin AmericaCompletedNCT03942497
- Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional TherapyCompletedNCT03941262Phase 1
- Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular LymphomaCompletedNCT03939026Phase 1
- Effect of Saline Irrigation in Reducing Choledocholithiasis Recurrence After ERCPCompletedNCT03937037Not applicable
- A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular LymphomaActive, not recruitingNCT03934567Phase 2
- A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)Active, not recruitingNCT03930953Phase 1/2
- Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC PatientsStatus unknownNCT03925896Phase 1
- 18F-Fluciclovine PET and Multiparametric MR ImagingWithdrawnNCT03925675Phase 2
- Jejunoileal vs Gastric GIST in the Era of Imatinib.CompletedNCT03923400
- CAR-T Cell Therapy Targeting to CD19 for R/R ALLActive, not recruitingNCT03919240Phase 1/2
- Preventive Use of COrticosteroids During the Post-Partum in Relapsing MS Patients (COPP-MS)CompletedNCT03917589
- MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian CancerStatus unknownNCT03916679Phase 1/2
- A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic ResectionStatus unknownNCT03914352Not applicable
- Apatinib in the Treatment of Recurrence or Metastasis of Esophageal CancerStatus unknownNCT03913182Phase 2
- Chiauranib in Combination With Chemotherapy in Patients With Ovarian CancerCompletedNCT03901118Phase 2
- Factors Predicting Recurrence in Rectal Cancer After SurgeryCompletedNCT03899870
- Confirmation Bias Towards Treatments of Depressive Disorders in Social TaggingCompletedNCT03899168Not applicable
- Hematogenous Osteomyelitis in Childhood Can Relapse Dozens of Years in AdulthoodCompletedNCT03898219
- Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer)TerminatedNCT03891576Phase 2
- The Physical Dosimetry Study and Preliminary Clinical Results of 3D-printing Non Co-planar Template Assisted With CT-guidance for Iodine-125 Seed Brachytherapy in Pelvic Recurrent Rectum Carcinoma After Surgery and External Beam RadiotherapyCompletedNCT03890926
- A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic MalignanciesCompletedNCT03886831Phase 1
- Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.TerminatedNCT03886649Phase 1
- Effectiveness of Two Types of Fixed Lingual Retainers in Preventing Mandibular Incisor RelapseCompletedNCT03881813Not applicable
- Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell MalignanciesStatus unknownNCT03881774Phase 1
- CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell LymphomaStatus unknownNCT03881761Phase 1
- Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile InfectionCompletedNCT03880539Phase 4
- Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R POMESStatus unknownNCT03879382Phase 1
- Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma PatientsTerminatedNCT03876028Phase 1
- A Study of CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-Cell LymphomaWithdrawnNCT03873025Phase 1/2
- Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower LimbsCompletedNCT03868956Not applicable
- Cold Snare Endoscopic Mucosal Resection TrialActive, not recruitingNCT03865537Not applicable
- A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid TumorsTerminatedNCT03861403Phase 1
- Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic VisitsCompletedNCT03856060Not applicable
- The Effect of Secondary Prevention in Patients With Recurrent Low Back PainCompletedNCT03852667Not applicable
- KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal CarcinomaCompletedNCT03848286Phase 2
- Nationwide Long-term Outcome Surveillance of Physiomesh® vs. Other Meshes in Laparoscopic Incisional Hernia RepairCompletedNCT03846661Not applicable
- Curcumin/Turmeric as a Treatment for Patients With Subdural Hematomas RecurrenceWithdrawnNCT03845322Early Phase 1
- Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple MyelomaActive, not recruitingNCT03836014Phase 3
- MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA UsersStatus unknownNCT03830827Phase 4
- Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AMLStatus unknownNCT03825367Phase 1/2
- The Effects of AMPC in the Treatments of Refractory or Relapsed AMLStatus unknownNCT03825146Phase 1
- Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCLCompletedNCT03820596Phase 1/2
- A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple MyelomaStatus unknownNCT03815383Phase 1
- Stress-related Predictor Profiles in Human AddictionCompletedNCT03810924Not applicable
- Study of TG-1801 in Subjects With B-Cell LymphomaCompletedNCT03804996Phase 1
- MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian CancerStatus unknownNCT03799913Early Phase 1
- Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell CarcinomaStatus unknownNCT03799744Phase 1
- Trial With Eribulin or Eribulin+ Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer PatientsTerminatedNCT03795012Phase 2
- Primary Care Transfer for Thyroid Cancer PatientsActive, not recruitingNCT03794375Not applicable
- Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the BloodActive, not recruitingNCT03793478Phase 1/2
- Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected WomenStatus unknownNCT03789513Not applicable
- Study of Cosibelimab in Subjects With Relapsed or Refractory LymphomaTerminatedNCT03778073Phase 1
- A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell LymphomaStatus unknownNCT03776279Phase 2
- Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring)CompletedNCT03772197
- Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic MalignanciesStatus unknownNCT03771222Phase 2
- A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)Status unknownNCT03770988Phase 2
- Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete ResponseStatus unknownNCT03767452Phase 4
- Registry of BrentuximabVedotinin Patients With R/R Anaplastic Large Cell Lymphoma or Classical HLCompletedNCT03766516
- Lentivirally Redirected CD123 Autologous T Cells in AMLTerminatedNCT03766126Phase 1
- Dexamethasone in Refractory or First Relapsed Acute Myeloid LeukemiaTerminatedNCT03765541Phase 3
- Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their ParentsCompletedNCT03765099Not applicable
- Modification of Goal-directed and Habitual Behavior in AddictionCompletedNCT03764969Not applicable
- Human Leukocyte Antigen Typing and Tumor Antigen Expression ProfilingCompletedNCT03760952
- IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid TumorsCompletedNCT03758781Phase 1
- Flexor Tenosynovectomy to Treat Recurrent Carpal Tunnel SyndromeTerminatedNCT03757416
- Mesh and Mesh Fixation in Laparoscopic Groin Hernia SurgeryCompletedNCT03755219
- Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic LeukemiaTerminatedNCT03755154Phase 1